Skip to main content

Table 1 Patient characteristics and demographics

From: MRI utility in the detection of disease activity in clinically stable patients with multiple sclerosis: a retrospective analysis of a community based cohort

Description

Mean (SD) or %

Number

Age, mean years (SD)

51.2 (11.7)

517

Female, %

82

424

MS Pattern, %

  

 Relapsing Remitting MS

94.2 %

487

 Clinically Isolated Syndrome

5.8 %

30

Duration of Disease, mean years (SD)

12 (7.5)

363

Years of Current DMT Use, mean (SD)

5.73 (3.75)

432

Health Insurance, %

  

 Private

81.5

422

 Medicare

12.4

64

 Public

3.1

16

 Other

0.2

1

 None

2.5

13

Current DMT, %

  

 IFNB 1a

77.8

402

 IFNB 1b

1.4

7

 GA

20.8

108

  1. Abbreviations: DMT disease modifying therapy, IFNB interferon beta, GA glatiramer acetate